These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 30185773)

  • 21. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Hang L; Kumar S; Blum AM; Urban JF; Fantini MC; Weinstock JV
    J Immunol; 2019 Apr; 202(8):2473-2481. PubMed ID: 30850474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children.
    Ajduk J; Marinic I; Aberle N; Rabatic S; Gagro A
    Ann Allergy Asthma Immunol; 2008 Apr; 100(4):314-22. PubMed ID: 18450115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
    Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
    Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of novel CD8
    Fan JN; Ho H; Chiang BL
    Cell Mol Life Sci; 2024 Aug; 81(1):327. PubMed ID: 39085655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerogenic dendritic cells induced the enrichment of CD4
    Jia L; Lu J; Zhou Y; Tao Y; Xu H; Zheng W; Zhao J; Liang G; Xu L
    Clin Immunol; 2018 Dec; 197():118-129. PubMed ID: 30248398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of murine and human Treg subsets in inflammatory bowel disease.
    Sun X; He S; Lv C; Sun X; Wang J; Zheng W; Wang D
    Mol Med Rep; 2017 Sep; 16(3):2893-2898. PubMed ID: 28677759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression.
    Zhang Y; Yao YM; Huang LF; Dong N; Yu Y; Sheng ZY
    J Interferon Cytokine Res; 2011 Feb; 31(2):249-57. PubMed ID: 21087077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD69: an unexpected regulator of TH17 cell-driven inflammatory responses.
    Martín P; Sánchez-Madrid F
    Sci Signal; 2011 Mar; 4(165):pe14. PubMed ID: 21427408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells.
    Winstead CJ; Fraser JM; Khoruts A
    J Immunol; 2008 Jun; 180(11):7305-17. PubMed ID: 18490730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C/EBPβ Deletion Promotes Expansion of Poorly Functional Intestinal Regulatory T Cells.
    Collins CB; Puthoor PR; Nguyen TT; Strassheim D; Jedlicka P; Friedman JE; de Zoeten EF
    J Crohns Colitis; 2018 Nov; 12(12):1475-1485. PubMed ID: 30085016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression.
    Radstake TR; van Bon L; Broen J; Wenink M; Santegoets K; Deng Y; Hussaini A; Simms R; Cruikshank WW; Lafyatis R
    PLoS One; 2009 Jun; 4(6):e5981. PubMed ID: 19543397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The suppressive effect of CD25+Treg cells on Th1 differentiation requires cell-cell contact partially via TGF-β production.
    Shen E; Zhao K; Wu C; Yang B
    Cell Biol Int; 2011 Jul; 35(7):705-12. PubMed ID: 21314640
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Zhou L; Liu D; Xie Y; Yao X; Li Y
    Gut Liver; 2019 Mar; 13(4):430-439. PubMed ID: 30600673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammation-induced CD69
    Zhang X; Jiang Z; Gu Y; Liu Y; Cao X; Han Y
    Sci China Life Sci; 2016 Dec; 59(12):1259-1269. PubMed ID: 27933593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation.
    Sojka DK; Hughson A; Fowell DJ
    Eur J Immunol; 2009 Jun; 39(6):1544-51. PubMed ID: 19462377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.